Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa
about
Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysisProportion and determinants of tuberculosis among human immunodeficiency virus-positive patients attending the antiretroviral therapy center attached to a Medical College in South IndiaFrequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique.Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART.Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey.Predictors of tuberculosis and human immunodeficiency virus co-infection: a case-control studyDeterminant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control studyNon-injection drug use and HIV disease progression in the era of combination antiretroviral therapy.Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur.Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in Uganda.Comparison of methods for correction of mortality estimates for loss to follow-up after ART initiation: a case of the Infectious Diseases Institute, Uganda.The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort studyLoss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South AfricaAge, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapySub-optimal CD4 T-lymphocyte responses among HIV infected patients who develop TB during the first year of ART.Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria.Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes.Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapyPredictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa.Systematic review of statistically-derived models of immunological response in HIV-infected adults on antiretroviral therapy in Sub-Saharan AfricaTuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatmentTuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort studyRegional differences in predictive accuracy of WHO immunologic failure criteriaTuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.High rates of tuberculosis in patients accessing HAART in rural South Africa.A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South AfricaRisk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.An observational study on the incidence of tuberculosis among a cohort of HIV infected adults in a setting with low prevalence of tuberculosis.Incidence of Tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa.Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda.Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition
P2860
Q27012753-94A08E54-B90A-4537-98F5-930E4A51D5DBQ30388126-5D935DD7-7A72-4AF0-A64A-3FC7403D5CD4Q33707759-BF2CC474-2329-4A7F-BD03-DD9B3C45CFCBQ34151023-28A8E7C2-1C2D-4C1D-9134-84915904EE42Q34222186-53461C66-409D-4C63-9D8D-E9BF25946744Q34383081-0B1FCD3D-9EBB-4032-8E33-C1DB0C11EB38Q34416963-8C9A9920-3DDE-483F-A15A-53162130E1DEQ34563388-13BC9A32-802F-44F9-B9D0-C0BD9A5B3464Q34634820-C94A1806-3A62-42BD-9670-02F01DEE712DQ34648833-C923ADE8-FED8-489C-A883-297FBF190DBFQ34769326-F0F1DE53-97F7-467A-A7E5-E40B6444D174Q34851665-E51E8CF9-73FB-4AF1-AF04-0AF009799AD5Q34981015-54C37711-D597-4215-B7FE-4AC9B5BBB2BFQ34988482-DC8E65E6-F5FE-43B5-9B60-058AA506BD4AQ35082510-AA5A541F-01B7-43E9-B726-799C67F4BF8FQ35544835-A08A7ADB-BF7F-4AC2-B924-00282D67FAA4Q35613107-49D644C5-5293-4A8A-9071-BB070C72CF9AQ35836400-40E08805-B9F9-492D-A669-D25CD26D0E48Q35842314-CC9ED4FE-4F1A-458A-BEC7-D8D5B4066F36Q35898590-C7907D4F-0ED6-4F01-B676-7212FBA3F896Q36047903-D057ECDD-8EDA-4942-998E-AF92422C1416Q36078532-DA825097-3AE1-4898-9C81-C46F3614E3BFQ36275193-6E8E485D-AB34-47CD-BCD2-3CE307AA0A99Q36281213-B572DB23-7AB1-42CE-A3C2-9D03D42B01B1Q36302953-278D1123-AEBC-46A8-B22A-871D4068CE2CQ36304210-DC98C021-D2AE-47C8-9670-1987B5A207B3Q36554005-93C7EE17-72E4-4C24-BE3A-1B7084F6B8B2Q36842083-E3F8560E-1434-45B4-915C-757B4D8987A5Q37267332-BF71C68D-55D6-431D-A211-ED05A8EA0FE7Q37461120-43775C2D-CCD1-47E7-85C6-6586FDB7E751Q37619616-CEF50216-3FC7-426C-98DD-6397E528F60BQ38644445-696A7F46-A81D-4815-B1CE-0B9058357C6BQ38662366-FB9A70D8-A20E-4B73-9035-1346FBE142C0Q38866845-D8C6206D-F31C-49AB-8DDB-1244CF272C0BQ38868438-85DFFB78-DE69-49D6-93C3-405FEC9FC758Q40625474-556C55EA-7073-46BA-A9BD-5B76D4B995C4Q41989084-CD5A2CF5-CDDF-4C1C-A95F-086FAA981CE4Q47547617-023610DC-B936-451D-AEDC-D2A0997D6454Q48142377-83693465-217C-4F8D-8462-625A21CE80A8Q57632324-721C5863-0C3E-457E-A398-43297C7E5B7C
P2860
Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@ast
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@en
Incident tuberculosis during a ...... clinic in sub-Saharan Africa.
@nl
type
label
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@ast
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@en
Incident tuberculosis during a ...... clinic in sub-Saharan Africa.
@nl
prefLabel
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@ast
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@en
Incident tuberculosis during a ...... clinic in sub-Saharan Africa.
@nl
P2093
P2860
P921
P1433
P1476
Incident tuberculosis during a ...... V clinic in sub-Saharan Africa
@en
P2093
Andrew Kambugu
Andy I M Hoepelman
Petra Schaefer
Sabine M Hermans
Yukari C Manabe
P2860
P304
P356
10.1371/JOURNAL.PONE.0010527
P407
P577
2010-05-07T00:00:00Z